Yong'an Pharma reports slumps in H1 results, while Jinyao Pharma's H1 net profit grows substantially

Summary: In H1 2023, Yong'an Pharma's revenue from taurine fell by 42.95% YoY because its taurine export business was impeded; gross profit margin of Jinyao Pharma's amino acid APIs grew by 7.35 percentage points YoY, marking the highest growth speed...

Amino Acids China E-News 202309